Blocking CD80/CD86 at a later stage or selectively blocking CD80 alone can reduce the progression of graft arterial disease, but early graft loss was not prevented by CD80 blockade alone, unlike the more effective CD80/CD86 double blockade. Here, CD80 is linked to arterial disorder.